Global Anti-Obesity Prescription Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

This study researches the market size of Anti-Obesity Prescription, presents the global Anti-Obesity Prescription sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.

This report focuses on the key data information of Anti-Obesity Prescription in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Anti-Obesity Prescription for each region and countries in each region.

For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.

This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Obesity is a public health problem. Obesity is a genetic and chronic metabolic disease involving accumulation of excessive or abnormal fat in the body. It contributes to risk of chronic conditions such as cancer, hypertension, cardiovascular diseases, diabetics, obstructive sleep apnea, ventilatory failure, renal failure and asthma. According to a World Health Organization (WHO) report published in 2014, around 3.4 million adults in the world die each year due to obesity related issues. Increasing prevalence of obesity among children and adults is posing a threat and developing nations. Effective intervention strategies such as increased physical activity, behavioral and dietary changes are commonly used to control and prevent obesity. Obesity has a major impact on population longevity and health related expense.

There is increased use of anti-obesity prescription due to increasing obesity endemic. Sedentary lifestyle and junk food habits, increasing healthcare expenditure and rise in aging population are some of the key factors driving the growth for global anti-obesity prescription market. In addition, increasing healthcare awareness is also fuelling the growth of the global anti-obesity prescription market. However, side effects of anti-obesity drugs, high drug development cost and strict regulatory framework are some of the major factors restraining the growth for the global anti-obesity prescription market. 

This report includes the following manufacturers; we can also add the other companies as you want.

    Zydus Cadila

    Akrimax Pharmaceuticals

    Zealand Pharma

    Arrowhead Research

    Arena Pharmaceuticals

    Compellis Pharmaceuticals

    Yungjin Pharm

    Alpex Pharma

    Bridge BioResearch

Market Segment by Product Type

    Bupropion and Naltrexone

    Orlistat

    Lorcaserin

    Phentermine and Topiramate

    Liraglutide

Market Segment by Application

    Hospital Pharmacies

    Retail Pharmacies

    E-Commerce

The study objectives are:

    To analyze and research the global Anti-Obesity Prescription status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

    To present the key Anti-Obesity Prescription manufacturers, capacity, production, revenue, market share, and recent development for key players.

    To split the breakdown data by regions, type, companies and applications.

    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

    To identify significant trends, drivers, influence factors in global and regions.

    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Request Sample Report and TOC@ http://www.qyresearchglobal.com/goods-1808798.html

About Us:

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.

QY Research Achievements:  

Year of Experience: 11 Years

Consulting Projects: 500+ successfully conducted so far

Global Reports: 5000 Reports Every Years

Resellers Partners for Our Reports: 150 + Across Globe

Global Clients: 34000+

Contact US

QY Research, INC.

Tina

17890 Castleton, Suite 218,

City of industry, CA – 91748

USA: +1 626 295 2442

Email: sales@qyrsearchglobal.com

Web: www.qyresearchglobal.com

For other region, contact number given below

+86 108 294 5717 Beijing

+852 3062 8839 HK

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.

Room 2901 VILI International Building No.167 Linhe West Road

This release was published on openPR.